-
Study aim
-
Determining the effect of Brightonic training on plasma levels of interleukin-17 (IL17), interleukin-4 (IL4), ratio of interleukin-17 to interleukin-4, Dual Task and functional test, PVT cognitive test, cognitive profile questionnaire of POMS mood modification, fatigue correction MFIS, St. Petersburg Sleep Quality and Vickery Quality of Life for MS Patients
-
Design
-
The research project will have 3 training and control groups, with parallel groups, blinded, randomized, on 45 patients. Simple randomization and toss throwing will be used for randomization.
-
Settings and conduct
-
The full implementation of this research project in the pre-test and post-test period will be done in the MS clinic of Imam Hossein hospital.
-
Participants/Inclusion and exclusion criteria
-
Inclusion criteria: patients with recurrent and clinically stable MS, a minimum disability (EDSS) below 3, the age range of 20 to 50 years.
Exclusion criteria: cardiovascular disease, diabetes, thyroid disorders, gout, orthopedic restrictions, patients who have an attack 4 weeks before or during the project.
-
Intervention groups
-
Patients will be randomly divided into 3 groups: aerobic-cognitive training, aerobic training and control.
-
Main outcome variables
-
Brightonic training on plasma levels of interleukin-17 (IL17), interleukin-4 (IL4), interleukin-17 to interleukin-4 ratio, Dual Task and TUG functional test, PVT cognitive test, POMS mood profile cognitive questionnaire tests, modified fatigue MFIS will affect the quality of sleep in St. Petersburg and the quality of life of Vicky patients with MS.